A source close to the company says the round assigns Science a post-money valuation of $1.25 billion.
“Science Corp. is betting on PRIMA, a chip said to be smaller than a grain of rice that, when implanted in the eye, works with camera-equipped glasses to restore functional vision to people suffering from advanced macular degeneration.”
Browse more
View all ArticlesContribute to FoundryBase
Sign in to suggest resources and start building your own collection.